Which jobs were cut at CDC? Here's a list.
The document, shared during an agency meeting Tuesday, paints a picture of a Centers for Disease Control and Prevention that will be more narrowly focused on infectious disease, with a significantly less holistic view of public health. The job cuts include the elimination of about a fourth of the staff at the National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention and about a third of the workers at the CDC's Injury Center.
'When you see the elimination of the Office of Smoking and Health, when smoking is the leading preventable cause of chronic disease, you have to ask the question, 'What are they thinking?' asked Dr. Richard Besser, CEO of the Robert Wood Johnson Foundation and a former acting director of the agency.
The cuts are part of a large-scale restructuring at the Department of Health and Human Services — with the goal of eliminating 10,000 employees, 2,400 from CDC. A spokesperson for HHS did not respond to a request asking whether changes to the staff reductions had been made since they were shared with staff Tuesday. ABC News reported that HHS Secretary Robert F. Kennedy Jr.
plans to reinstate
some workers who were mistakenly fired.
Here are the cuts:
— National Center for Chronic Disease Prevention and Health Promotion was reduced by about a third, losing the Office on Smoking and Health, Oral Health, Population Health, and some of the Reproductive Health divisions.
— The Office of Health Equity was eliminated. The parts of its work that are written into law will go to the Office of Minority Health and the Office of Women's Health.
— Discretionary programs were cut from the National Institute for Occupational Safety and Health, leaving behind only the mandatory World Trade Center health program and the Radiation Dose Reconstruction Program. The Trump administration plans to fold NIOSH into a new HHS agency called the Administration for a Healthy America.
— The cuts dissolve the Birth Defects Center, but retain some of its work, including the Surveillance for Emerging Threats to Mothers and Babies Network. Some birth defects surveillance will continue, as well as autism surveillance.
— The National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention lost about a fourth of its staff. The biggest cuts came from the Division of HIV Prevention. The Global Health Center Division of Global HIV & TB was also reduced by roughly a fourth.
— CDC's Injury Center lost roughly a third of its staff. It will retain the Overdose Prevention Division and suicide prevention branch. Some surveillance activities will continue, like the National Violent Death Reporting System and 'adverse childhood experience' monitoring.
— The National Center for Environmental Health lost its Division of Environmental Health Science and Practice. The Agency for Toxic Substances and Disease Registry will be folded into the Administration for a Healthy America.
— The National Center for Immunization and Respiratory Diseases lost its partnership and health equity branch.
— The media support, broadcast services, visual design, and content and engagement branches were cut from the Office of Communications.
— The Office of Acquisition Services in the Office of Financial Resources and the Office of Human Resources saw big cuts, while the Office of Equal Employment Opportunity was eliminated.
— The CDC's office tasked with responding to Freedom of Information Act requests was cut. The administration plans to create one FOIA office for all of HHS.
— The Administration for Strategic Preparedness and Response lost 81 staff, according to an HHS official granted anonymity to discuss the cuts. Around a dozen of those let go were Strategic National Stockpile employees who worked in state, local, tribal and territorial programs, while others worked on grant management. Around 30 of the layoffs were from the Biomedical Advanced Research and Development Authority, the person said.
The Trump administration has not publicly released a detailed overview of cuts at HHS, of which CDC is part, leading to confusion about the reorganization.
'The important next step for HHS is to answer questions from Congress, release a chart [of the cuts], share information with partners, and make sure that state and local health departments who carry this work out in communities across the country know who to call,' said Chrissie Juliano, executive director of the Big Cities Health Coalition, a forum of leaders from the nation's largest urban public health departments.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
Infectious Disease Therapies Market Projected to Reach $101 Billion by End of 2030
"As infectious diseases like HIV, hepatitis, tuberculosis, and influenza continue to challenge global health systems, new breakthroughs such as long acting injectables and monoclonal antibodies are driving better patient outcomes and fueling market growth, especially in the face of rising drug resistance." BOSTON, Aug. 14, 2025 /PRNewswire/ -- According to the latest study from BCC Research, "Global Markets for Infectious Disease Treatments" is expected to grow from $72.5 billion in 2025 to $101 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.9% during the forecast period of 2025 to 2030. This report analyzes the global market for infectious disease therapeutics, vaccines, and diagnostics, covering diseases such as HIV, influenza, hepatitis B and C, RSV, TB, HSV, malaria, rotavirus, and viral hemorrhagic fevers. It highlights market trends, challenges, and opportunities, along with insights into new products, acquisitions, collaborations, and ESG developments. The report also ranks leading companies by market share and provides detailed profiles of them. Excluded from the report are vector control strategies, symptomatic treatments, generic suppliers, and certain hospital-based diagnostic methods. This report is particularly relevant today because the COVID-19 pandemic has reshaped global priorities around infectious diseases. It exposed critical gaps in healthcare systems and underscored the urgent need for rapid diagnostics, effective treatments, and scalable vaccine platforms. In response, governments, organizations, and private companies invested in infectious disease research and infrastructure, driving innovation and global collaboration. The pandemic also highlighted the importance of early detection, surveillance, and preparedness, leading to renewed attention on emerging and neglected infectious diseases. The factors driving the market's growth include: Increasing Resistance to Drugs: Drug resistance is rising as bacteria and viruses evolve to withstand existing treatments, making infections harder to cure. This pushes pharmaceutical companies to develop new drugs and therapies, driving growth in the infectious disease treatment market. Global Efforts to Combat Infectious Diseases: Governments and international organizations are investing in public health initiatives, research, and vaccination programs to control infectious diseases. These efforts create strong support for treatment development and expand market opportunities worldwide. Technological Advances in Diagnostics and Therapeutics: Innovations like rapid testing, AI-based drug discovery, and advanced vaccines are improving how diseases are detected and treated. These technologies enhance efficiency and effectiveness, boosting demand for more effective diagnostic and therapeutic solutions. Climate Change: Changing climate patterns are expanding the reach of disease-carrying organisms, leading to the spread of infections in new regions. This increases the need for treatments in previously unaffected areas, stimulating market expansion and adaptation. Request a sample copy of the global market for infectious disease treatments report. Report Synopsis Report Metric Details Base year considered 2024 Forecast period considered 2025-2030 Base year market size $68.3 billion Market size forecast $101 billion Growth rate CAGR of 6.9% for the forecast period of 2025-2030 Segments covered Product, Disease, and Region Regions covered North America, Europe, Asia-Pacific, Middle East and Africa, and South America Countries covered U.S., Canada, Mexico, U.K., Germany, France, China, India, and Japan Market drivers • Increasing resistance to drugs. • Global efforts to combat infectious diseases. • Technological advances in diagnostics and therapeutics. • Climate change. • Increase in international travel. Interesting facts: More than 85% of hepatitis B virus infections never receive a diagnosis. Due to climate change, mosquito-borne infectious diseases are on the rise. The worldwide incidence of dengue has risen eightfold in the past 20 years. Emerging startups: Codagenix: The company develops vaccines and viral therapeutic candidates for infectious diseases. Its intranasal vaccine candidate, CoviLiv, is a live-attenuated vaccine against COVID-19. nChroma Bio: A biotechnology company advancing genetic medicines. CRMA-1001 is an epigenetic editor in development as a potential treatment for chronic hepatitis B and hepatitis D. The company plans to submit a clinical trial application in 2025. The report addresses the following questions: What are the projected size and growth rate of the Infectious disease treatments market?- The global Infectious disease treatments market was estimated at $68.3 billion in 2024. The market is projected to reach $101 billion in 2030, growing at a CAGR of 6.9% during the forecast period. Which market segments are covered in the report?- The report includes historical data and market projection on sales by product type, disease, and region. Which product type segment will be dominant through 2030?- Therapeutics is expected to have the largest share of the product type segment through the end of 2030. Which product type is showing the fastest growth?- The vaccine segment is the fastest growing product type segment. What are the key challenges and opportunities in the market?- Challenges: Pricing pressure is a significant factor restraining the growth of the infectious disease treatment market, particularly in low and middle-income countries where healthcare budgets are limited. Lack of awareness and underdiagnosis remain major barriers to the growth of the infectious disease treatment market.- Opportunities: Self-testing kits are rapidly gaining traction in the field of infectious diseases, offering individuals convenient, private, and timely diagnostic options. Market leaders include: ABBOTT ABBVIE INC. CSL DANAHER CORP. F. HOFFMANN-LA ROCHE LTD. GILEAD SCIENCES INC. GSK PLC JOHNSON & JOHNSON MERCK & CO. INC. MOLBIO DIAGNOSTICS LTD. ORASURE TECHNOLOGIES INC. PFIZER INC. SANOFI SERUM INSTITUTE OF INDIA PVT. LTD. SIEMENS HEALTHINEERS Related reports: The Global Influenza Market: This report provides a comprehensive review of the global influenza market, offering qualitative and quantitative insights. It explores the historical context of flu pandemics, current disease burden, and vaccine coverage across key regions. The market is segmented into vaccines (inactivated and live-attenuated), therapeutics, and diagnostics (rapid and conventional tests), with detailed analysis of each category. It also highlights leading products, clinical trials, new approvals, and emerging technologies. Regional demographics and growth prospects in North America, Europe, and Asia-Pacific are examined, along with strategic profiles of major companies operating in the influenza sector. Purchase a copy of the report direct from BCC Research. For further information on any of these reports or to make a purchase, contact info@ About BCC Research BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype. Contact Us Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USA Email: info@ Phone: +1 781-489-7301 For media inquiries, email press@ or visit our media page for access to our market research library. Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. Logo - View original content to download multimedia: SOURCE BCC Research LLC Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Indianapolis Star
2 hours ago
- Indianapolis Star
We can't make Indiana healthy again until we fix our food supply
Unhealthy food is addictive, cheap and takes up the majority of our grocery stores. To make things worse, the federal and local governments are largely to blame. Indiana, for its part, ranks ninth worst in the nation for obesity and 14th worst in overall public health. Thankfully, state legislators are starting to address this, inspired by Robert F. Kennedy Jr. to 'Make Indiana Healthy Again.' As a result, the state recently banned certain unhealthy foods from the food stamps program. Indiana also has several agricultural programs meant to develop a healthier overall food supply. The root causes of Indiana's nutritional public health crisis, however, extend much deeper. The Farm Bill of 1973 introduced a policy that set a target price for crops and paid farmers for deficiencies with the actual price. This policy evolved into the Price Loss Coverage Program, which pays farmers if the market price of their crop drops below a reference point set by the government. This program allowed larger agricultural operations to overproduce certain crops while still reaping significant profits. As a result, it incentivized some farmers to take on debt to expand their operations and led others to consolidate. Opinion: Steak 'n Shake's MAGA makeover is a desperate bid to save a dying business By one estimate, total farm debt increased from $52.8 billion in 1970 to $178.7 billion in 1980, according to a study by the University of Illinois. Meanwhile, since 2010, 345,000 acres of farmland and over 3,050 farms have disappeared in Indiana. The supply of corn, soybean and wheat products, which make up the basis of ultraprocessed food, subsequently skyrocketed. Corn production alone more than doubled from 1969 to 2022 in Indiana. Corn syrup became the most common sweetener found in food at the grocery store. 'There is a huge disconnect between an agriculture that is extremely efficient and productive, but is no where close to the best we could do if vibrant rural communities and a healthy population was the goal,' Greg Gunthorp told me. He runs an independent family farm in LaGrange. Whole Farm Revenue Protection, created in 2014, is a better alternative to the PLC program. This government-subsidized insurance program reduces income volatility for farmers without subsidizing the overproduction of certain crops or disproportionately benefitting larger producers. It can cover up to $17 million in revenue and pays out if the farm's overall income is less than its insured amount due to issues like low prices, low yields or natural disasters. Replacing the PLC and similar programs would remove some of the incentives that make ultra-processed, unhealthy foods so common and give smaller farms a better shot at competing with large producers. This would also reduce the need for Indiana's Speciality Crop Block Grant, intended to level the playing field for crops like fruits, vegetables, tree nuts and dried fruits. Many local governments in Indiana have also needlessly made organic, small-scale farming initiatives difficult. One example: Cities and towns surrounding Indianapolis, including Greenwood, Brownsburg, Anderson, Lawrence, Franklin and Danville, ban backyard chickens. Others have arbitrary regulations that are nearly impossible to satisfy. Plainfield, for example, requires homeowners to have two acres of land to keep chickens at a time when farmland prices have reached record highs, while Shelbyville requires coops to be 200 feet away from neighbors. Other cities including Beech Grove, Southport and Carmel arbitrarily limit homeowners to six backyard chickens, regardless of the size of their property. Hicks: Braun's plan for Indiana's small towns will only hasten their decline With farmland values rapidly rising, it is often difficult for people and organizations prioritizing healthy food, sustainability and self-sufficiency to afford acreage outside of their homes and outside of city limits. One piece of state legislation addressed these issues. An early version of Senate Enrolled Act 14 would have given Indiana residents the 'right to grow, raise, produce, harvest, and consume the food that the individual chooses for the individual's own nourishment, sustenance, bodily health, and well-being." In effect, it would have superced local regulations that make small-scale farming impossible, while allowing localities to maintain evidence-based regulations to preserve public health. In its final form, however, the legislation only protected the right of homeowners to grow a vegetable garden. Lt. Gov. Micah Beckwith, whose role involves supporting innovation in agriculture, told me his office tried to rally support for House Bill 1562, which would have banned local governments from enacting stricter regulations on small farm and home-based vendors than the federal government. 'I don't think anyone is arguing for no regulation, no common sense regulatory authority,' Beckwith said. 'I think it's just sometimes, we know in government … regulations just grow upon each other.' Hicks: America's debt crisis will force red states to pay their own way for once The bill passed the House of Representatives but did not receive a hearing in the Senate Committee on Agriculture. A spokesperson for State Sen. Jean Leising, R-Oldenburg, said she did not give it a hearing due to 'food safety concerns expressed by many in the agricultural industry.' One has to wonder if those same agricultural industry lobbyists are as concerned about food safety when it comes to the negative health impact of ultra-processed foods and unsustainable farming practices. If these arbitrary local regulations on small farms and home-based vendors were removed, the availability of locally sourced, healthier, organic food would likely increase. State programs focused on increasing the accessibility of healthy, locally sourced food, including the Resilient Food Systems Infrastructure Grant and the Farm to School program, would also likely become more efficient. Opinion: In Indiana, tax cuts always win while successful programs lose Clearly, there is a growing interest in locally sourced, healthier food, especially following the COVID-19 pandemic. 18.3 million people started gardening and there was a 5% increase in backyard chicken owners around that time. Local governments need to recognize this and get out of the way. Nationally, the Make America Healthy Again movement has focused on small changes, like convincing Coca-Cola to use cane sugar and banning some artificial dyes. It has largely avoided making substantive changes to the root causes that incentivized unhealthy food to take over our grocery stores and our diets in the first place. One root cause is long-term changes in our food supply, which have helped make Indiana one of the unhealthiest states in one of the unhealthiest developed nations in the world. If we really want to make Indiana healthy again, we need to fundamentally change the agricultural policies that kicked off those changes.
Yahoo
6 hours ago
- Yahoo
CDC director: Misinformation 'lead to deadly consequence" in Atlanta
Aug. 13 (UPI) -- The director of the Centers for Disease Control and Prevention told employees about the dangers of misinformation, four days after a suspected gunman shot at the agency's headquarters in Atlanta, claiming the COVID-19 vaccine made him sick. On Tuesday, Susan Monarez met with staffers virtually and then sent a note to all 10,000 employees nationwide, obtained by ABC News. Staffers at the headquarters have been working remotely since the attack on Friday. "The dangers of misinformation and its promulgation has now led to deadly consequences," she wrote. "I will work to restore trust in public health to those who have lost it -- through science, evidence and clarity of purpose. I will need your help." The comments were slightly different than those during her staff meeting in which she said: "Public health should never be under attack. We know that misinformation can be dangerous." She said the health agency can rebuild trust with "rational evidence-based discourse" with "compassion and understanding." Dr. Paul Offit, the director of the Vaccine Education Center at Children's Hospital of Pennsylvania, told NBC News: "The irony is her boss is the biggest spreader of misinformation." Robert F. Kennedy Jr. is secretary of the Health and Human Services, which oversees the CDC. In 2021, during the pandemic, Kennedy described the shot as the "deadliest vaccine ever made" after he filed a citizens' petition requesting that the Food and Drug Administration end emergency authorization. Last week, Kennedy announced that HHS was moving to terminate $500 million in contracts to develop vaccines using mRNA technology, which was used to develop the COVID-19 vaccine in 2020. "After reviewing the science and consulting top experts at NIH [National Institutes of Health] and FDA, HHS has determined that mRNA technology poses more risks than benefits for these respiratory viruses," The American Medical Association backs mRNA vaccine research and the CDC still says on its website: "During the COVID-19 pandemic, COVID-19 vaccines underwent the most intensive safety analysis in U.S. history." Health officials have denounced skepticism of the research, noting the COVID-19 vaccine saved millions of lives in the United States. "The Covid pandemic showed us what's possible when science moves fast," Rick Bright, who directed the Biomedical Advanced Research and Development from 2016 to 2020, told NBC News. "Dismantling that momentum now is like disbanding the fire department because the fire's out." As head of the HHS, he has updated COVID-19 vaccine recommendations for the fall to be restricted to older adults and those with underlying health conditions. He also doesn't want children to get the shots. On Monday, Kennedy toured the CDC campus in Atlanta and met with the widow of the one person slain in the attack, DeKalb County Police Officer David Rose. He toured with Monarez and HHS Deputy Secretary Jim O'Neill. "He offered his deepest condolences and reaffirmed the agency's commitment to honoring officer Rose's bravery, sacrifice and service to the nation," HHS said. Since the attack, the union representing CDC workers condemned the lack of support from top officials. "This leadership is critical in reinforcing public trust and ensuring that accurate, science-based information prevails," the union said Sunday. "This condemnation is necessary to help prevent violence against scientists that may be incited by such disinformation." The American Federation of Government Employees Local 2883, which represents more than 2,000 CDC workers, said in a statement Sunday that the attack "was not random and it compounds months of mistreatment, neglect and vilification that CDC staff have endured." The union also said: "The deliberate targeting of CDC through this violent act is deeply disturbing, completely unacceptable and an attack on every public servant." The father of the suspected gunman, 30-year-old Patrick Joseph White, reportedly told authorities he targeted the CDC over health problems he blamed on the COVID-19 vaccine. He said the shot made him depressed and suicidal. He was fatally shot by police after around 200 bullets struck the six buildings. Five firearms were recovered. "All indications are that this was an isolated event involving one individual," Jeff Williams, the deputy secretary of the CDC's Office of Safety, Security and Asset Management, said during the staff meeting Tuesday.
